Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PhaseBio Pharmaceuticals Inc | 41,236 | reported | 20 May 2022 | tx 20+288,108−17,774 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 10,917 | 0.68 USD | |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 87,500 | 0.00 USD | deriv |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 18,750 | 0.00 USD | deriv |
| 19 Nov 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 2,559 | 2.01 USD | |
| 12 Jul 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 4,519 | 1.74 USD | |
| 20 May 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 5,257 | 2.80 USD | |
| 05 Feb 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 36,000 | 0.00 USD | deriv |
| 20 Nov 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 4,832 | 3.00 USD | |
| 01 Oct 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,423 | 1.15 USD | |
| 27 Feb 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,423 | 1.15 USD | |
| 01 Oct 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,423 | 1.15 USD | deriv |
| 27 Feb 2020 | EXERCISE | PhaseBio Pharmaceuticals Inc | 5,423 | 1.15 USD | deriv |
| 12 Feb 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 55,000 | 0.00 USD | deriv |
| 27 Feb 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 45,000 | 0.00 USD | deriv |
| 22 Oct 2018 | CONVERSION | PhaseBio Pharmaceuticals Inc | 2,306 | — | |
| 22 Oct 2018 | EXERCISE | PhaseBio Pharmaceuticals Inc | 103 | 0.00 USD | deriv |
| 22 Oct 2018 | CONVERSION | PhaseBio Pharmaceuticals Inc | 2,306 | 0.00 USD | deriv |
| 22 Oct 2018 | EXERCISE | PhaseBio Pharmaceuticals Inc | 103 | 0.12 USD | deriv |